254 related articles for article (PubMed ID: 9751121)
21. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
[TBL] [Abstract][Full Text] [Related]
22. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
23. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
24. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth.
Van Nguyen A; Pollard JW
Dev Biol; 2002 Jul; 247(1):11-25. PubMed ID: 12074549
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
26. Conditional knockout of Lgr4 leads to impaired ductal elongation and branching morphogenesis in mouse mammary glands.
Oyama K; Mohri Y; Sone M; Nawa A; Nishimori K
Sex Dev; 2011; 5(4):205-12. PubMed ID: 21791950
[TBL] [Abstract][Full Text] [Related]
27. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli.
Jones FE; Jerry DJ; Guarino BC; Andrews GC; Stern DF
Cell Growth Differ; 1996 Aug; 7(8):1031-8. PubMed ID: 8853899
[TBL] [Abstract][Full Text] [Related]
28. Growth of mouse mammary glands after neonatal sex hormone treatment.
Tomooka Y; Bern HA
J Natl Cancer Inst; 1982 Dec; 69(6):1347-52. PubMed ID: 6958910
[TBL] [Abstract][Full Text] [Related]
29. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development.
Xie W; Paterson AJ; Chin E; Nabell LM; Kudlow JE
Mol Endocrinol; 1997 Nov; 11(12):1766-81. PubMed ID: 9369445
[TBL] [Abstract][Full Text] [Related]
30. Local effects of EGF, alpha-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo.
Vonderhaar BK
J Cell Physiol; 1987 Sep; 132(3):581-4. PubMed ID: 3498730
[TBL] [Abstract][Full Text] [Related]
31. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
32. Uterine and vaginal organ growth requires epidermal growth factor receptor signaling from stroma.
Hom YK; Young P; Wiesen JF; Miettinen PJ; Derynck R; Werb Z; Cunha GR
Endocrinology; 1998 Mar; 139(3):913-21. PubMed ID: 9492020
[TBL] [Abstract][Full Text] [Related]
33. Role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland.
Ankrapp DP; Bennett JM; Haslam SZ
J Cell Physiol; 1998 Feb; 174(2):251-60. PubMed ID: 9428811
[TBL] [Abstract][Full Text] [Related]
34. Progesterone alone is responsible for stimulation of the growth of ducts and of mammary alveolar structures in mice.
Skarda J; Fremrová V; Bezecný I
Endocrinol Exp; 1989 Mar; 23(1):17-28. PubMed ID: 2714223
[TBL] [Abstract][Full Text] [Related]
35. Estrogen affects development of alveolar structures in whole-organ culture of mouse mammary glands.
Barlow J; Casey T; Chiu JF; Plaut K
Biochem Biophys Res Commun; 1997 Mar; 232(2):340-4. PubMed ID: 9125177
[TBL] [Abstract][Full Text] [Related]
36. Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.
Accornero P; Miretti S; Bersani F; Quaglino E; Martignani E; Baratta M
PLoS One; 2012; 7(9):e44982. PubMed ID: 23028720
[TBL] [Abstract][Full Text] [Related]
37. Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland.
Jäger R; Schäfer S; Hau-Liersch M; Schorle H
Dev Dyn; 2010 Mar; 239(3):1027-33. PubMed ID: 20131354
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.
Ruan W; Kleinberg DL
Endocrinology; 1999 Nov; 140(11):5075-81. PubMed ID: 10537134
[TBL] [Abstract][Full Text] [Related]
39. Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density.
Kornilova ES; Taverna D; Hoeck W; Hynes NE
Oncogene; 1992 Mar; 7(3):511-9. PubMed ID: 1347917
[TBL] [Abstract][Full Text] [Related]
40. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.
Daniel CW; Silberstein GB; Strickland P
Cancer Res; 1987 Nov; 47(22):6052-7. PubMed ID: 3664507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
